Ipsen and Roche sign deal for Type 2 diabetes drug
The Wall Street Journal Europe
20 Jul 2006
FRENCH pharmaceuticals company Ipsen SA said it signed a licensing agreement with drug maker Roche Holding AG for a diabetic treatment that could earn the company as much as OE229 million ($286 million), excluding royalties. Roche, based in... read more...
posted by Bank Report at
6:46 PM
0 Comments:
Post a Comment
<< Home